Global Peri-Implantitis Market to Reach US$1.6 Billion by 2030

The global market for Peri-Implantitis estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Non-Surgical Type, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$866.0 Million by the end of the analysis period. Growth in the Surgical Type segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$292.3 Million While China is Forecast to Grow at 9.8% CAGR

The Peri-Implantitis market in the U.S. is estimated at US$292.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$315.7 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Peri-Implantitis Market - Key Trends & Drivers Summarized

What Is Peri-Implantitis and Why Is It Emerging as a Dental Health Concern?

Peri-implantitis is a progressive inflammatory condition affecting soft and hard tissues around dental implants, leading to bone loss and potential implant failure. It typically develops from poor plaque control, mechanical overload, or systemic health factors such as diabetes or smoking. As dental implants become more widespread, peri-implantitis is being increasingly recognized as a significant complication requiring timely diagnosis and intervention.

Unlike peri-implant mucositis, which is confined to soft tissue inflammation, peri-implantitis involves irreversible bone damage. This condition can result in pain, implant mobility, and even loss of the implant. As implant procedures rise globally in both restorative and cosmetic dentistry, awareness and clinical management of peri-implantitis are becoming critical to maintaining long-term success rates.

How Are Diagnosis and Treatment Modalities Evolving in Clinical Practice?

Diagnosis is based on clinical assessment of inflammation, bleeding on probing, increased pocket depth, and radiographic bone loss. Advances in diagnostic tools, including digital imaging, 3D cone-beam computed tomography, and peri-implant tissue biomarkers, are enabling earlier and more accurate detection. Standardized diagnostic protocols are also being developed to differentiate peri-implantitis from other inflammatory conditions.

Treatment options include mechanical debridement, antiseptic irrigation, systemic or local antibiotics, and surgical intervention such as guided bone regeneration or implant surface decontamination. Emerging therapies include laser-assisted debridement, photodynamic therapy, and biologic agents to promote bone healing. Implant design and surface coatings are being modified to reduce biofilm adhesion and enhance tissue integration, thus lowering risk of recurrence.

Where Is Clinical Demand Increasing and Which Stakeholders Are Focusing on Solutions?

Dental clinics, periodontists, and implantology centers are the primary settings for managing peri-implantitis. Demand is rising in both developed and emerging markets due to greater use of implants in aging populations, aesthetic dentistry, and full-arch rehabilitation. Patients with risk factors such as poor oral hygiene, history of periodontitis, or smoking are more likely to develop complications, prompting clinicians to adopt preventive and early-intervention strategies.

Dental device manufacturers, biomaterials developers, and oral hygiene product companies are investing in innovations to address peri-implantitis. Academic research is also expanding into regenerative therapies and biofilm control strategies. Integration of digital health records and regular implant maintenance programs is helping dental professionals monitor implant health more closely and reduce the burden of late-stage peri-implant disease.

Growth in the Peri-Implantitis market is driven by several factors…

Growth in the peri-implantitis market is driven by factors such as rising global prevalence of dental implants, increased recognition of implant-related complications, and evolving standards in oral healthcare. Demand for advanced diagnostics, effective treatment protocols, and implant maintenance solutions is increasing among dental professionals seeking to preserve implant longevity.

Technological improvements in surgical techniques, implant surface modification, and non-invasive therapies are broadening clinical options for intervention. Regulatory emphasis on implant safety and post-market surveillance is also promoting investment in peri-implantitis prevention and management tools. With the aging population and growing use of implant-supported prosthetics, peri-implantitis management is becoming a vital segment within periodontal and restorative dentistry.